04.17.24 -- A Guide To Proactive Supplier Management In The Pharma/Biotech Industry

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

A panel of product development experts examines blind spots that can plague early development strategies, as well as important considerations when navigating the path toward an IND submission.

Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.

Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.

Recent advances in nanoparticle engineering technology promise to improve the success rate of new drug candidates and help push novel therapies to market.

As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.

Orally disintegrating tablets enhance pharmacokinetics and improve compliance. Zydis® fast dissolve can enhance your investment and increase your product’s potential.